25 results
424B3
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
16 Jan 07
Prospectus supplement
12:00am
Corporation, a
public specialty pharmaceutical company, until its acquisition by Stiefel
Laboratories, Inc. in December 2006. During his tenure of nearly
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
12 Apr 13
Amendments to Articles of Incorporation or Bylaws
12:00am
such duties as shall be determined from time to time by the Board.
Section 3. Tenure, Removal and Vacancies. The officers of the corporation shall hold
S-4
EX-3.3
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
.
Section 3. Tenure, Removal and Vacancies. The officers of the
corporation shall hold office until their successors are chosen and qualified
8-K
EX-3.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
.
Section 3. Tenure, Removal and Vacancies. The officers of the corporation shall hold office until their successors are chosen and qualified. Any officer
8-K
EX-3.1
pseyak 43
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
EX-99.1
oyyhuua4wfn8v
12 Mar 19
Regulation FD Disclosure
10:02am
SC TO-T
EX-99
ekhlx6zuwx5lqxczqtcc
31 Aug 20
Third party tender offer statement
8:46am
S-4
EX-10.3
3iqn34n brhiotzzmm9
9 Jul 98
Registration of securities issued in business combination transactions
12:00am